Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01354743 · ClinicalTrials.gov registry record · Phase 4
Upper Facial Remodeling With Perlane-L and Dysport
A Phase 4 study, sponsored by Beer, Kenneth R., M.D., PA.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT01354743 is a Phase 4 study that has completed, run by Beer, Kenneth R., M.D., PA. The registered enrollment target is 20 participants.
The verdict
NCT01354743, a Phase 4 study, has completed, sponsored by Beer, Kenneth R., M.D., PA.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to provide data to support combination treatment of the upper face with Perlane-L® and Dysport™. This study will assess the outcome of upper face rejuvenation in the temporal fossa; outcome of glabella and/or periorbital regions will also be assessed as a secondary endpoint.
Interventions
- DRUG Dysport
- DEVICE Perlane L
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2010-12 |
| Est. Completion | 2012-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01354743
The ClinicalTrials.gov registry entry for NCT01354743 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beer, Kenneth R., M.D., PA, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dysport is the first listed.
NCT01354743 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01354743 about?
NCT01354743 is a clinical study titled "Upper Facial Remodeling With Perlane-L and Dysport". The purpose of this study is to provide data to support combination treatment of the upper face with Perlane-L® and Dysport™. This study will assess the outcome of upper face rejuvenation in the temporal fossa; outcome of glabella and/or periorbital regions will also be assessed as a secondary endpo...
What is the current status of trial NCT01354743?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2010-12. Estimated completion is 2012-05.
What interventions are being tested in trial NCT01354743?
The interventions under investigation include: Dysport (DRUG), Perlane L (DEVICE).
Who is sponsoring clinical trial NCT01354743?
This trial is sponsored by Beer, Kenneth R., M.D., PA, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.